U-Turn: NICE Recommends Rituximab, Humira In Arthritis Indications After Second Review
This article was originally published in The Pink Sheet Daily
Executive Summary
U.K. agency reverses unfavorable preliminary opinions based on submissions from Roche and Abbott.